Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vaxart Inc (NQ: VXRT )

0.6100 +0.0108 (+1.80%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vaxart Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Vaxart Stock Is Moving Higher After The Bell: What's Going On?
Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project... 
Via Benzinga
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID-19 vaccine study. 
Via Benzinga
Exposures COVID-19
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning! 
Via InvestorPlace
Recap: Vaxart Q4 Earnings
Via Benzinga
Vaxart's Earnings: A Preview
Via Benzinga
What's Going On With Vaxart Stock Today?
Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services. 
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Earnings Preview For Vaxart
Via Benzinga
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside
Oppenheimer initiates Vaxart coverage with an Outperform rating and $4 price target, citing a bullish outlook on its oral vaccines for COVID-19 and norovirus. 
Via Benzinga
Exposures COVID-19
VXRT Stock Earnings: Vaxart Misses EPS, Beats Revenue for Q2 2024
VXRT stock results show that Vaxart missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Vaxart's Earnings Outlook
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Palo Alto Networks Shares Drop After Q3 Results, In-Line Guidance: The Details
Palo Alto Networks reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.25 by 5.6%. Quarterly sales clocked in at $1.985 billion which beat the analyst... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
VXRT Stock Earnings: Vaxart Meets EPS, Beats Revenue for Q1 2024
VXRT stock results show that Vaxart met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Vaxart Stock Climbs After Blockbuster Q1 Revenue
Vaxart reported quarterly losses of 14 cents per share, inline with the analyst consensus estimate. Quarterly sales clocked in at $2.181 million, beating the analyst consensus estimate of $800,000 by... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around. 
Via InvestorPlace
VXRT Stock Earnings: Vaxart Beats EPS, Beats Revenue for Q4 2023
VXRT stock results show that Vaxart beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
What's Going On With Vaxart (VXRT) Stock?
Vaxart shares are trading higher by 17.8% Tuesday morning amid multiple news items. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services. 
Via Benzinga
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.